HPR Dr. Schaffler GmbH
- Address
- lock Available on a paid plan
HPR Dr. Schaffler GmbH - Pain Research Specialists
HPR Dr. Schaffler GmbH is a specialized clinical research facility focused on advancing pain management therapies through rigorous early-phase clinical trials. The center maintains expertise in evaluating novel analgesic compounds in healthy volunteer populations, contributing essential safety and efficacy data that shapes the development of next-generation pain medications.
- Novel analgesic compound evaluation and pharmacological assessment
- Pain management therapy development in controlled clinical settings
- Safety and tolerability profiling of investigational pain medications
The research center conducts comprehensive studies examining pain medication effectiveness and safety profiles in healthy participants, providing critical foundational data for pharmaceutical development. Their methodical approach to evaluating experimental compounds like BHV-2100 and BHV-7000 demonstrates their commitment to advancing therapeutic options for patients suffering from various pain conditions.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in HPR Dr. Schaffler GmbH
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of the Efficacy, Safety, and Tolerability of BHV-2100 and BHV-7000 in the Management of Pain in Healthy Male Subjects | Biohaven Therapeutics Ltd. | Phase I | Not Recruiting | Oct 2024 | Dec 2024 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.